Total neoadjuvant treatment in locally advanced rectal cancer

Translational Oncology - Tập 14 - Trang 101044 - 2021
Francesca De Felice1, Vincenzo Tombolini1, Enrico Cortesi2
1Department of Radiotherapy, Policlinico Umberto I “Sapienza” University of Rome, Viale Regina Elena 326, 00161, Rome, Italy
2Medical Oncology Department, Policlinico Umberto I, “Sapienza” University of Rome, Italy

Tài liệu tham khảo

De Felice, 2017, Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis: oxaliplatin in neoadjuvant treatment for rectal cancer, BMC Cancer, 17, 325, 10.1186/s12885-017-3323-4

van der Valk, 2020, Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - results of the international randomized RAPIDO-trial, Radiother. Oncol., 147, 75, 10.1016/j.radonc.2020.03.011

Fokas, 2020, Outcome measures in multimodal rectal cancer trials, Lancet Oncol., 21, e252, 10.1016/S1470-2045(20)30024-3

Benson, 2018, Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology, J. Natl. Compr. Cancer Netw., 16, 874, 10.6004/jnccn.2018.0061

De Felice, 2018, Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study, Oncotarget, 9, 33702, 10.18632/oncotarget.26101